Which closed-end funds own Drugs Made In America Acquisition Corp?
1 active closed-end fund report this security in their latest N-PORT filing, with a combined reported value of $11K. Security type: equity derivative. Country: United States. CUSIP G2847J112 · ISIN KYG2847J1123 · ticker DMAAR.
Holdings are historical filings (report dates Jun 30, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| RIV RiverNorth Opportunities Fund | Multi-Asset | 0.00% | $11K | 100,000 NC | $434M | 10.7% discount | Jun 30, 2026 |
1 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Drugs Made In America Acquisition Ii Corp | common equity | 1 |
| Drugs Made In America Acquisition Ii Corp | equity derivative | 1 |
Issuer-level search for “DMAAR” → · Compare two funds’ portfolios →